Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory DME [NA]
This clinical trial update describes a study of PPV with ILM peeling, with or without subretinal injection of Ringer's lactate, for nontract…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial reporting short-term outcomes of the dexamethasone intravitreal implant in patients with refractory diabetic macular …
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) [Phase 4]
A Phase 4 clinical trial evaluating ILUVIEN (intravitreal fluocinolone acetonide) as baseline therapy for patients with early diabetic macul…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: VISUPRIME® Eye Drops [NA]
Clinical trial update noting the completion of a VISUPRIME Eye Drops study sponsored by VISUfarma SpA for several retinal diseases.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
A completed clinical trial evaluated a deep learning model to detect and classify diabetic retinopathy from posterior pole retinal images, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Gene Therapy for DME [Phase 1, Phase 2]
A Phase 1/2 gene therapy trial for diabetic macular edema sponsored by Frontera Therapeutics is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy
A Zhejiang University study is evaluating artificial intelligence systems for assisted diagnosis of diabetic retinopathy and diabetic macula…
-
FDA approval · 2024-07-03FDA Approved: VABYSMO — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for VABYSMO (faricimab) submitted by Genentech, Inc., indicating an update to the product labeling o…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Exploring the Interaction Between Metabolic Disorders and NLPR3 Inflammasome Activation in DR Inflammatory Damage
A clinical trial is investigating how metabolic disorders influence NLPR3 inflammasome activation and inflammatory damage in diabetic retino…
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Effectiveness Of Suprachoroidal Injection In Diabetic Macular Edema
This update discusses a clinical trial evaluating the effectiveness of suprachoroidal injections for diabetic macular edema. The trial is cu…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema [Phase 4]
A Phase 4 study comparing dexamethasone intravitreal implant to intravitreal aflibercept in diabetic macular edema has completed.
-
CLINICAL_TRIALS withdrawal · 2024-06-05Clinical Trial Update: Unilateral Bevacizumab for Bilateral Diabetic Macular Edema [Phase 4]
A Phase 4 trial evaluating unilateral bevacizumab for bilateral diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: iOCT for Patients With Diabetic Macular Edema [NA]
A completed clinical trial update evaluating the use of intraoperative optical coherence tomography (iOCT) in patients with diabetic macular…
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema [Phase 3]
A Phase 3 trial evaluating intravitreal bevacizumab for diffuse diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: POSTERIOR SUB-TENON'S Avastin [Phase 4]
A Phase 4 clinical trial of Avastin (bevacizumab) delivered via posterior sub-Tenon’s injection for diabetic macular edema has been withdraw…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema [Phase 3]
A Phase 3 trial evaluating the combination of vitrectomy and bevacizumab for diffuse diabetic macular edema has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study [Phase 3]
Phase 3 trial comparing intravitreal Kenalog, intravitreal Bevacizumab, and control for diffuse diabetic macular edema was withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT) [Phase 4]
This Phase 4 FORESIGHT trial update reports changes in inflammatory biomarkers, including soluble CD14 and hyperreflective foci, in patients…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD) [Phase 2]
Phase 2 BEHOLD study assessing safety, tolerability, and preliminary activity of UBX1325 in diabetic macular edema; results have been posted…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
A completed clinical trial evaluating hybrid deep learning algorithms to detect eye diseases from fundus images. The study targeted conditio…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME) [Phase 2]
Phase 2 clinical trial update showing completion of the study evaluating CU06-1004 in Diabetic Macular Edema.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, and initial efficacy of SKG0106 given by intravitreal injection in patients wi…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME [Phase 3]
A DRCR.Net Phase 3 trial comparing aflibercept monotherapy to bevacizumab with deferred aflibercept for central-involved diabetic macular ed…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Clinical Study of the Safety and Efficacy of BAT5906 Injection [Phase 1, Phase 2]
Clinical study evaluating safety and efficacy of BAT5906 Injection in diabetic macular edema completed (Phase 1 and Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: One Year Trial Evaluating Safety of Ozurdex With Eylea [Phase 4]
A Phase 4 trial evaluating the safety of Ozurdex with Eylea in diabetic macular edema has completed.